Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants

医学 阿哌沙班 拜瑞妥 达比加群 内科学 倾向得分匹配 肾功能 比例危险模型 冲程(发动机) 回顾性队列研究 心房颤动 危险系数 人口 低风险 华法林 置信区间 机械工程 环境卫生 工程类
作者
Justin Ashley,Eric McArthur,Sarah E. Bota,Ziv Harel,Marisa Battistella,Amber O. Molnar,Min Jun,Sunil V. Badve,Amit X. Garg,Douglas G. Manuel,Peter Tanuseputro,Philip S. Wells,Thomas A. Mavrakanas,Emily Rhodes,Manish M. Sood
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:76 (3): 311-320 被引量:21
标识
DOI:10.1053/j.ajkd.2020.02.446
摘要

Rationale & Objective Evidence for the efficacy of direct oral anticoagulants (DOACs) to prevent cardiovascular (CV) events and mortality in older individuals with a low estimated glomerular filtration rate (eGFR) is lacking. We sought to characterize the association of oral anticoagulant use with CV morbidity in elderly patients with or without reductions in eGFRs, comparing DOACs with vitamin K antagonists (VKAs). Study Design Population-based retrospective cohort study. Settings & Participants All individuals 66 years or older with an initial prescription for oral anticoagulants dispensed in Ontario, Canada, from 2009 to 2016. Exposure DOACs (apixaban, dabigatran, and rivaroxaban) compared with VKAs by eGFR group (≥60, 30-59, and <30 mL/min/1.73 m2). Outcomes The primary outcome was a composite of a CV event (myocardial infarction, revascularization, or ischemic stroke) or mortality. Secondary outcomes were CV events alone, mortality, and hemorrhage requiring hospitalization. Analytical Approach High-dimensional propensity score matching of DOAC to VKA users and Cox proportional hazards regression. Results 27,552 new DOAC users were matched to 27,552 new VKA users (median age, 78 years; 49% women). There was significantly lower risk for CV events or mortality among DOAC users compared with VKA users (event rates of 79.78 vs 99.77 per 1,000 person-years, respectively; HR, 0.82 [95% CI, 0.75-0.90]) and lower risk for hemorrhage (event rates of 10.35 vs 16.77 per 1,000 person-years, respectively; HR, 0.73 [95% CI, 0.58-0.91]). There was an interaction between eGFR and the association of anticoagulant class with the primary composite outcome (P < 0.02): HRs of 1.01 [95% CI, 0.92-1.12], 0.83 [95% CI, 0.75-0.93], and 0.75 [95% CI, 0.51-1.10] for eGFRs of ≥60, 30 to 59, and <30 mL/min/1.73 m2. No interaction was detected for the outcome of hemorrhage. Limitations Retrospective observational study design limits causal inference; dosages of DOACs and international normalized ratio values were not available; low event rates in some subgroups limited statistical power. Conclusions DOACs compared with VKAs were associated with lower risk for the composite of CV events or mortality, an association for which the strength was most apparent among those with reduced eGFRs. The therapeutic implications of these findings await further study. Evidence for the efficacy of direct oral anticoagulants (DOACs) to prevent cardiovascular (CV) events and mortality in older individuals with a low estimated glomerular filtration rate (eGFR) is lacking. We sought to characterize the association of oral anticoagulant use with CV morbidity in elderly patients with or without reductions in eGFRs, comparing DOACs with vitamin K antagonists (VKAs). Population-based retrospective cohort study. All individuals 66 years or older with an initial prescription for oral anticoagulants dispensed in Ontario, Canada, from 2009 to 2016. DOACs (apixaban, dabigatran, and rivaroxaban) compared with VKAs by eGFR group (≥60, 30-59, and <30 mL/min/1.73 m2). The primary outcome was a composite of a CV event (myocardial infarction, revascularization, or ischemic stroke) or mortality. Secondary outcomes were CV events alone, mortality, and hemorrhage requiring hospitalization. High-dimensional propensity score matching of DOAC to VKA users and Cox proportional hazards regression. 27,552 new DOAC users were matched to 27,552 new VKA users (median age, 78 years; 49% women). There was significantly lower risk for CV events or mortality among DOAC users compared with VKA users (event rates of 79.78 vs 99.77 per 1,000 person-years, respectively; HR, 0.82 [95% CI, 0.75-0.90]) and lower risk for hemorrhage (event rates of 10.35 vs 16.77 per 1,000 person-years, respectively; HR, 0.73 [95% CI, 0.58-0.91]). There was an interaction between eGFR and the association of anticoagulant class with the primary composite outcome (P < 0.02): HRs of 1.01 [95% CI, 0.92-1.12], 0.83 [95% CI, 0.75-0.93], and 0.75 [95% CI, 0.51-1.10] for eGFRs of ≥60, 30 to 59, and <30 mL/min/1.73 m2. No interaction was detected for the outcome of hemorrhage. Retrospective observational study design limits causal inference; dosages of DOACs and international normalized ratio values were not available; low event rates in some subgroups limited statistical power. DOACs compared with VKAs were associated with lower risk for the composite of CV events or mortality, an association for which the strength was most apparent among those with reduced eGFRs. The therapeutic implications of these findings await further study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
坚定岂愈发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
彭于晏应助农大彭于晏采纳,获得10
2秒前
3秒前
3秒前
优秀爆米花完成签到,获得积分10
4秒前
香蕉觅云应助听话的幼荷采纳,获得10
4秒前
4秒前
baekhyun发布了新的文献求助10
4秒前
5秒前
大意的羊发布了新的文献求助10
7秒前
7秒前
坚定岂愈完成签到,获得积分10
8秒前
情怀应助根决采纳,获得10
8秒前
8秒前
Qinjichao完成签到,获得积分10
9秒前
9秒前
9秒前
10秒前
10秒前
amongferns发布了新的文献求助10
11秒前
Owen应助来日方长采纳,获得10
11秒前
11秒前
NexusExplorer应助zhogwe采纳,获得10
12秒前
大胆石头发布了新的文献求助10
12秒前
FashionBoy应助温暖的纲采纳,获得200
12秒前
慕青应助甜甜小蜜蜂采纳,获得10
13秒前
13秒前
平常傲白发布了新的文献求助10
13秒前
14秒前
14秒前
14秒前
酷波er应助寻度采纳,获得10
15秒前
Xxxudi发布了新的文献求助10
16秒前
安详的雨兰完成签到 ,获得积分10
16秒前
volvoamg发布了新的文献求助10
17秒前
17秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
An Introduction to Geographical and Urban Economics: A Spiky World Book by Charles van Marrewijk, Harry Garretsen, and Steven Brakman 600
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3153667
求助须知:如何正确求助?哪些是违规求助? 2804835
关于积分的说明 7861986
捐赠科研通 2462948
什么是DOI,文献DOI怎么找? 1311018
科研通“疑难数据库(出版商)”最低求助积分说明 629429
版权声明 601821